Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care.

ABSTRACT:

Background

Patients with Philadelphia-negative Myeloproliferative Neoplasms (MPN) suffer from numerous symptoms and decreased quality of life. Smoking is associated with an increased symptom burden in several malignancies. The aim of this study was to analyze the association between smoking and MPN-related symptom burden and explore MPN patients' opinions on smoking.

Methods

A total of 435 patients with MPN participated in a cross-sectional internet-based survey developed by the Mayo Clinic and the Myeloproliferative Neoplasm Quality of Life Group. Patients reported their demographics, disease characteristics, tobacco use, and opinions on tobacco use. In addition, MPN-related symptoms were reported via the validated 10-item version of the Myeloproliferative Neoplasms Symptom

SUBMITTER: Christensen SF 

PROVIDER: S-EPMC8194237 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature